IN2013MU03909A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03909A IN2013MU03909A IN3909MU2013A IN2013MU03909A IN 2013MU03909 A IN2013MU03909 A IN 2013MU03909A IN 3909MU2013 A IN3909MU2013 A IN 3909MU2013A IN 2013MU03909 A IN2013MU03909 A IN 2013MU03909A
- Authority
- IN
- India
- Prior art keywords
- compound
- formula
- dimethyithiochroman
- thiochromans
- diynyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 229960000565 tazarotene Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000776 WO2015107542A2 (en) | 2013-12-13 | 2014-12-15 | Tazarotene with low dimer impurity for treating acne or psoriasis |
| US15/103,444 US9688667B2 (en) | 2013-12-13 | 2014-12-15 | Tazarotene with low dimer impurity for treating acne or psoriasis |
| IN3909MU2013 IN2013MU03909A (da) | 2013-12-13 | 2014-12-15 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3909MU2013 IN2013MU03909A (da) | 2013-12-13 | 2014-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03909A true IN2013MU03909A (da) | 2015-08-07 |
Family
ID=53543577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3909MU2013 IN2013MU03909A (da) | 2013-12-13 | 2014-12-15 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US9688667B2 (da) |
| IN (1) | IN2013MU03909A (da) |
| WO (1) | WO2015107542A2 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109081835B (zh) * | 2017-06-14 | 2022-04-12 | 重庆华邦胜凯制药有限公司 | 一种不使用碘化亚铜的他扎罗汀的制备方法 |
| US20210260055A1 (en) * | 2018-06-21 | 2021-08-26 | Dermavant Sciences GmbH | Topical formulations of dgat1 inhibitors and their methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006040644A2 (en) * | 2004-10-11 | 2006-04-20 | Ranbaxy Laboratories Limited | Processes for the preparation of substituted thiochroman derivatives |
| WO2009116075A2 (en) * | 2008-02-12 | 2009-09-24 | Indoco Remedies Limited | Process for preparation of tazarotene |
-
2014
- 2014-12-15 US US15/103,444 patent/US9688667B2/en not_active Expired - Fee Related
- 2014-12-15 IN IN3909MU2013 patent/IN2013MU03909A/en unknown
- 2014-12-15 WO PCT/IN2014/000776 patent/WO2015107542A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US9688667B2 (en) | 2017-06-27 |
| WO2015107542A2 (en) | 2015-07-23 |
| US20160304503A1 (en) | 2016-10-20 |
| WO2015107542A3 (en) | 2016-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200225A1 (ar) | مشتق كوينولين عالي النقاء وطريقة لإنتاجه | |
| CL2017002483A1 (es) | Compuestos heterocíclicos como inhibidores de lsd1 | |
| PH12016500225B1 (en) | Novel quinoline-substituted compound | |
| PH12015502546A1 (en) | 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient | |
| IN2014MN02496A (da) | ||
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| MX2016005760A (es) | Inhibidores de glucogeno sintasa cinasa 3 (gsk-3). | |
| MX2014014838A (es) | Nuevos derivados de depsipeptidos ciclicos y agentes para el control de organismos dañinos que comprenden los mismos. | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| PH12015502032A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| UA116258C2 (uk) | Заміщена похідна піразолілпіразолу та застосування її як гербіциду | |
| MX357763B (es) | Tratamiento para cancer pancreatico. | |
| CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
| PH12017501404A1 (en) | Diaza-benzofluoranthrene compounds | |
| MX2020009462A (es) | Procesos para la preparación de compuestos de pirimidinilciclopentano. | |
| EA201591449A1 (ru) | Способы получения противораковых композиций | |
| WO2015107542A3 (en) | Tazarotene with low dimer impurity for treating acne or psoriasis | |
| MX2016006807A (es) | Derivados de imidazol. | |
| MX2015014346A (es) | Metodo de uso mejorado del potencial de produccion de plantas transgenicas. | |
| MX2016002043A (es) | Imidazoles sustituidos como bloqueadores de canales de calcio tipo n. | |
| PH12015501840A1 (en) | Production method of pyridazinone compounds | |
| MX364769B (es) | Proceso para producir 2-fenil-1, 3-benzoxazoles. | |
| IN2013MU03015A (da) | ||
| IN2013MU01219A (da) | ||
| IN2013MU01355A (da) |